STERIS plc (NYSE:STE) SVP Sells $3,208,026.24 in Stock

STERIS plc (NYSE:STE - Get Free Report) SVP Cary L. Majors sold 12,828 shares of STERIS stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $250.08, for a total transaction of $3,208,026.24. Following the completion of the sale, the senior vice president now directly owns 11,372 shares of the company's stock, valued at approximately $2,843,909.76. This trade represents a 53.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

STERIS Trading Up 0.0%

Shares of STE traded up $0.09 during mid-day trading on Friday, hitting $245.09. The company had a trading volume of 1,044,282 shares, compared to its average volume of 546,540. STERIS plc has a 1-year low of $200.98 and a 1-year high of $252.79. The business's 50-day simple moving average is $227.95 and its 200-day simple moving average is $220.77. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market cap of $24.08 billion, a PE ratio of 52.04 and a beta of 0.96.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, May 14th. The medical equipment provider reported $2.74 earnings per share for the quarter, topping analysts' consensus estimates of $2.59 by $0.15. STERIS had a net margin of 8.66% and a return on equity of 13.91%. The business had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same quarter last year, the company earned $2.58 earnings per share. The business's quarterly revenue was up 5.7% compared to the same quarter last year. Sell-side analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th will be paid a $0.57 dividend. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 annualized dividend and a dividend yield of 0.93%. STERIS's dividend payout ratio is currently 36.77%.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Geneos Wealth Management Inc. grew its position in STERIS by 416.0% in the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 104 shares in the last quarter. Avalon Trust Co bought a new stake in shares of STERIS in the 4th quarter worth about $30,000. Human Investing LLC bought a new stake in shares of STERIS in the 4th quarter worth about $31,000. Grove Bank & Trust grew its holdings in STERIS by 4,733.3% during the 1st quarter. Grove Bank & Trust now owns 145 shares of the medical equipment provider's stock worth $33,000 after acquiring an additional 142 shares during the last quarter. Finally, Anfield Capital Management LLC grew its holdings in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 91 shares during the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on STE. Wall Street Zen downgraded shares of STERIS from a "strong-buy" rating to a "buy" rating in a report on Friday. Citigroup restated an "outperform" rating on shares of STERIS in a research report on Friday, May 16th. Stephens reiterated an "overweight" rating and issued a $250.00 target price on shares of STERIS in a research report on Thursday, May 15th. Morgan Stanley raised their price target on shares of STERIS from $240.00 to $260.00 and gave the stock an "equal weight" rating in a research note on Monday, May 19th. Finally, Piper Sandler lifted their target price on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $263.83.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.